Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up
Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders
AMD Ryan Initiative Study
Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma ( MAC)
An Observational Prospective Natural History Study of Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
A Survey Study of Retinitis Pigmentosa (RP) Clinical Measures and Repeatability Testing of Potential Outcome Measures.
Pilot Evaluation of Potential Environmental Causes of Uveal Coloboma
The Genetics of Inherited Eye Disease
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions
Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants
Genotype - Phenotype Study of Patients With Plaquenil-induced Retinal Toxicity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)